Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

US Patent 11478526 · Granted Oct 25, 2022

Estimated economic value: $483,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and AS2023
Peptides and methods for treatment of neurodegenerative diseases2020
Peptides and methods for treatment of neurodegenerative diseases2020
Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and AS2020
Modulation sAPP, sAAP α and BDNF levels in individuals diagnosed with FXS and AS2017
Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple2015
CD28 mimetics for blocking T cell mediated immune reactions2007